Non-survivors were older, male subjects with a longer duration of HF, higher C-reactive protein and NT-proBNP levels, more often had kidney dysfunction, were more often diagnosed with diabetes mellitus, anaemia and ischaemic heart disease and were less often treated with beta-blocking agents in comparison with survivors. This evidence concerns the gene NPPB and anemia (phenotype).